These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

525 related items for PubMed ID: 7831584

  • 1. All-trans-retinoic acid in acute promyelocytic leukemia and its potential in other hematologic malignancies.
    Tallman MS.
    Semin Hematol; 1994 Oct; 31(4 Suppl 5):38-48. PubMed ID: 7831584
    [Abstract] [Full Text] [Related]

  • 2. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z, Cholovitsh M, Elezovitsh I, Vidovitsh A, Radoshevitsh-Radojkovitsh N, Boshkovitsh D, Novak A, Basara N.
    Srp Arh Celok Lek; 1995 Oct; 123(11-12):279-85. PubMed ID: 16296239
    [Abstract] [Full Text] [Related]

  • 3. [Clinical pharmacology of all-trans retinoic acid (ATRA)].
    Robak T.
    Acta Haematol Pol; 1995 Oct; 26(3):269-77. PubMed ID: 8525772
    [Abstract] [Full Text] [Related]

  • 4. Retinoic acid and acute promyelocytic leukemia: a model of targetting treatment for human cancer.
    Chen Z, Chen SJ, Wang ZY.
    C R Acad Sci III; 1994 Dec; 317(12):1135-41. PubMed ID: 7697468
    [Abstract] [Full Text] [Related]

  • 5. All trans retinoic acid.
    Advani SH.
    J Assoc Physicians India; 1995 Dec; Suppl 3():65-6. PubMed ID: 8773125
    [Abstract] [Full Text] [Related]

  • 6. All-trans-retinoic acid treatment and retinoic acid receptor alpha gene rearrangement in acute promyelocytic leukemia: a model for differentiation therapy.
    Degos L.
    Int J Cell Cloning; 1992 Mar; 10(2):63-9. PubMed ID: 1312109
    [Abstract] [Full Text] [Related]

  • 7. Differentiating therapy in acute myeloid leukemia.
    Tallman MS.
    Leukemia; 1996 Aug; 10(8):1262-8. PubMed ID: 8709629
    [Abstract] [Full Text] [Related]

  • 8. Differentiating therapy in acute myeloid leukemia.
    Tallman MS.
    Leukemia; 1996 Jun; 10 Suppl 2():s33-8. PubMed ID: 8649051
    [Abstract] [Full Text] [Related]

  • 9. [Treatment of acute promyelocytic leukemia by all trans retinoic acid].
    Castaigne S, Degos L.
    C R Seances Soc Biol Fil; 1995 Jun; 189(4):515-20. PubMed ID: 8564565
    [Abstract] [Full Text] [Related]

  • 10. Acute promyelocytic leukemia (AML-M3)--Part 2: Molecular defect, DNA diagnosis, and proposed models of leukemogenesis and differentiation therapy.
    Randolph TR.
    Clin Lab Sci; 2000 Jun; 13(2):106-16. PubMed ID: 11066449
    [Abstract] [Full Text] [Related]

  • 11. [Remission of acute promyelocytic leukemia after all-trans-retinoic acid].
    Knobel B, Sommer I, Meytes D.
    Harefuah; 1992 Dec 01; 123(11):445-8, 507. PubMed ID: 1487198
    [Abstract] [Full Text] [Related]

  • 12. Comparison of anthracycline-based combination chemotherapy with or without all-trans retinoic acid in acute promyelocytic leukemia.
    Raza S, Ullah K, Ahmed P, Khan B.
    J Coll Physicians Surg Pak; 2008 Sep 01; 18(9):546-50. PubMed ID: 18803891
    [Abstract] [Full Text] [Related]

  • 13. All-trans retinoic acid (ATRA) in the treatment of acute promyelocytic leukemia (APL).
    Chim CS, Kwong YL, Liang R, Chu YC, Chan CH, Chan LC, Wong KF, Chan TK.
    Hematol Oncol; 1996 Sep 01; 14(3):147-54. PubMed ID: 9119359
    [Abstract] [Full Text] [Related]

  • 14. Problems existing in differentiation therapy of acute promyelocytic leukemia (APL) with all-trans retinoic acid (ATRA).
    Wang ZY, Chen Z, Huang W, Li XS, Lu JX, Huang LA, Zhang FQ, Gu LJ, Ouyang RR, Chen SJ.
    Blood Cells; 1993 Sep 01; 19(3):633-41; discussion 642-7. PubMed ID: 8018944
    [Abstract] [Full Text] [Related]

  • 15. A unique case of acute promyelocytic leukemia showing monocytic differentiation after ATRA (all-trans retinoic acid) therapy.
    Naeem M, Harrison K, Barton K, Nand S, Alkan S.
    Eur J Haematol; 2006 Feb 01; 76(2):164-6. PubMed ID: 16405439
    [Abstract] [Full Text] [Related]

  • 16. [Differentiation therapy of acute promyelocytic leukemia with all-trans retinoic acid].
    Ohno R.
    Gan To Kagaku Ryoho; 1993 Feb 01; 20(2):189-93. PubMed ID: 8434955
    [Abstract] [Full Text] [Related]

  • 17. New strategies for the treatment of acute promyelocytic leukaemia.
    Mandelli F.
    J Intern Med Suppl; 1997 Feb 01; 740():23-7. PubMed ID: 9350178
    [Abstract] [Full Text] [Related]

  • 18. Role of all-trans-retinoic acid (ATRA) in the consolidation therapy of acute promyelocytic leukaemia (APL).
    Gupta V, Yi QL, Brandwein J, Lipton JH, Messner HA, Schuh AC, Wells RA, Minden MD.
    Leuk Res; 2005 Jan 01; 29(1):113-4. PubMed ID: 15541484
    [Abstract] [Full Text] [Related]

  • 19. Acute promyelocytic leukemia: recent advances in diagnosis and management.
    Lo-Coco F, Ammatuna E, Montesinos P, Sanz MA.
    Semin Oncol; 2008 Aug 01; 35(4):401-9. PubMed ID: 18692690
    [Abstract] [Full Text] [Related]

  • 20. Diagnosis and follow-up of acute promyelocytic leukemia by detection of PML-RAR alpha gene rearrangement.
    Gau JP, Young JH, Lin TH, Yang YS.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Mar 01; 63(3):175-81. PubMed ID: 10746412
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.